The more scientists learn about a disease, it seems, the less certain they are about the right treatment.
A vaccine (which contains either a dead or an attenuated form of a pathogen) lets the immune system learn about a disease without the body having to undergo the infection.
The Hunter eClinic represents an attempt to provide an effective approach to facilitate learning about a rare genetic disease through an interactive program covering the management of specific diagnostic and treatment problems in a virtual clinical setting, coupled with immediate access to a vast amount of resource material, as well as feedback to the learner on their effectiveness and efficiency.
Electronic methods such as the internet, email distribution lists and use of cell phones have significant potential in this area and the results of this study indicate that physicians reported them to be at least as useful as traditional methods as ways to obtain health information and most useful in for learning about a newly emerging disease (AI).
Thus, the physician who learns about a new disease adapts by perceiving material on the disease in medical literature, learning what the material contains, remembering the crucial aspects that are needed to treat the patient, and then utilizing reason to solve the problem of applying the information to the needs of the patient.
Overview of Lesson Plan: In this lesson, students learn about a deadly disease decimating the Tasmanian devil population.
2. Learn about a fatal disease decimating the Tasmanian devil population and efforts to protect them from extinction by reading and discussing the article "In Tasmania, the Devil Now Faces Its Own Hell".
In the context of WGS or WES, patients may seek genetic testing out of a belief that the information will help motivate them to pursue healthier behaviors, predicting that learning about an elevated risk of heart disease, for example, will spur them on to exercise or to go to the doctor for check-ups more regularly.
For most respondents, the possibility of learning more about a disease, and thus being better able to prevent it, would be a major motivation for consenting to a post-mortem needle biopsy.
However, on top of an awe-inspiring $100 million in donations, many people learned about a very frightening disease for the first time.
The dual purpose was to learn about a specific infectious disease and foster reflective practice.
